Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 904)
Posted On: 05/26/2017 1:17:01 AM
Post# of 72447
Avatar
Posted By: sox0407
Re: Chemdeps #34062
Yes, I think B-OM will be the first choice for anyone undergoing radiation and insurance companies will be happy to pay for it. The reason the trial only accepts head and neck cancer patients is because they are most likely to develop OM.

As for chemo, if the drug's side effect includes OM, doctors will definitely prescribe B-OM first. It's quite commom so chemo-induced OM could be more than the 500K radiation-induced OM. Plus it's rinse and spit at home, who hard can it be?

I expect the next interim update to be as impressive as the first one (> 50% in prevention). Hopefully it'll include the first 30 patients.

"Oral mucositis is a common complication of chemotherapy. It begins 5-10 days after the initiation of chemotherapy and lasts 7-14 days."

http://emedicine.medscape.com/article/1079570-overview













(8)
(0)






Dont-give-up.jpg



  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site